Herb Riband - Vice President Value, Access & Policy, Amgen / Board member, EBE
Short description of the presentation:
- What does it take to create and sustain a “biotech ecosystem of innovation” in Europe?
- What role does intellectual property play in driving this ecosystem?
- How can we ensure sustainable, high quality European healthcare systems by focusing on improving patient outcomes?
- How can we use big data/smart data to improve both R&D and healthcare delivery?
Biography of the speaker:
Herb Riband joined Amgen in 2012, based at the company’s European headquarters in Zug, Switzerland.
Mr. Riband leads Amgen’s Value, Access & Policy function in Europe, and its Policy & Government Affairs work in regions outside of the United States. He is responsible for anticipating and addressing the company’s market access and policy needs across multiple jurisdictions, serving as a senior leader of a global function and a member of Amgen’s European Management Committee. He also co-leads Amgen’s value-based healthcare program in Europe, which includes developing innovative “beyond the drug” approaches to healthcare delivery and promoting outcomes-focused healthcare policies.
Mr. Riband serves on the Board of Directors of EBE (European Biopharmaceutical Enterprises) and the International Committee of EFPIA, the Brussels-based European federation of research-based pharmaceutical industries and associations. He is also a member of the Global Health Council of Geneva-based IFPMA, the international federation that represents pharmaceutical manufacturers and associations from around the world.
Prior to joining Amgen, Mr. Riband worked with Medtronic, Inc. for 13 years in a variety of roles, including Vice President External Affairs for Medtronic's International region with responsibility for access, health economics, healthcare policy, government affairs and corporate philanthropy activities. In connection with this role, Mr. Riband was active in Eucomed, the European medical technology industry association, serving as Chair of the Public Affairs Network as well as on the International Affairs Group and Corporate Advisory Council. Mr. Riband also served as a member of two industry/government bodies, the UK Ministerial Medical Technology Strategy Group and the Geneva-based Council for Multilateral Business Diplomacy.
A native of Philadelphia, Pennsylvania, Mr. Riband received degrees from Cornell University (Ithaca, NY) and the University of Michigan Law School (Ann Arbor, MI). He is a citizen of Switzerland and the United States.